Table 1 Demographics of the study population, duration of disease, IF results, etc.
| Overall (n = 30) | MMP (oral only) (n = 19) | MMP (ocular and oral)(n = 11) | |
|---|---|---|---|
| Age at diagnosis (years) | |||
| Mean | 65.23 | 65.16 | 65.36 |
| Range | 46–84 | 46–84 | 51–81 |
| Sex (% men) | 16/30 (53%) | 11/19 (58%) | 5/11 (45.5%) |
| Race (% white) | 29/30 (97%) | 19/19 (100%) | 10/11 (91%) |
| Diagnostic delay >12/12 | |||
| Yes | 10 (33%) | 5 (26%) | 5 (45.5%) |
| No | 13 (43%) | 9 (48%) | 4 (36%) |
| Unknown | 7 (23%) | 5 (26%) | 2 (18%) |
| Duration of disease (years) | |||
| Mean | 5.8 | 5.4 | 6.5 |
| Range | 1–14 | 1–13 | 1–14 |
| DIF result (if known) | |||
| IgG | 2 | 2 | 0 |
| IgM | 1 | 1 | 0 |
| IgA | 3 | 0 | 3 |
| C3 | 1 | 1 | 0 |
| Mixed | 10 | 6 | 4 |
| Pattern of DIF (if known) | |||
| Granular | 1 | 0 | 1 |
| Linear | 10 | 5 | 5 |
| IIF result (if known) | |||
| Roof | 6 | 4 | 2 |
| Floor | 0 | 0 | 0 |
| Negative | 4 | 3 | 1 |
| Involvement of other sites | |||
| Anorectal/genital | 4 | 3 | 1 |
| Skin | 4 | 3 | 1 |
| Duration to first ocular review (months) | |||
| Mean | 19.3 | 21.5 | 15.5 |
| Range | 0‐144 | 0‐144 | 0‐108 |
| Eye symptoms at first ocular review (yes) | 9/30 (30%) | 0 (0%) | 9/11 (83.2%) |
DIF, direct immunofluorescence; IIF, indirect immunofluorescence; MMP, mucous membrane pemphigoid.